期刊论文详细信息
BMC Public Health
The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort
Jing Yuan3  Weihong Chen3  Tangchun Wu3  Jungang Xie2  Xiaosheng He3  Fan Hou3  Bing Zhang3  Xin Luo3  Zhihong Zhang3  Yanjun Guo3  Yuqing Yang3  Xiuqing Cui3  Yun Zhou3  Huizhen Sun3  Yi Rong3  Aijun Tan1  Xiaomin Zhang3  Xiji Huang3  Jian Hou3  Yuanchao Song3 
[1] Zhuhai Center for Disease Control & Prevention, Zhuhai, China;Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;Key Laboratory of Environment and Health in Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
关键词: Cardiovascular diseases;    Respiratory diseases;    Pulmonary function;    Particulate matter;    Air pollutants;    Cohort study;   
Others  :  1126678
DOI  :  10.1186/1471-2458-14-994
 received in 2014-07-29, accepted in 2014-09-19,  发布年份 2014
PDF
【 摘 要 】

Background

Particulate air pollution has been recognized to be associated with a wide range of adverse health effects, including increased mortality, morbidity, exacerbation of respiratory conditions. However, earlier physiological or pathological changes or long-term bodies’ reaction to air pollutants have not been studied in depth in China. The Wuhan-Zhuhai (WHZH) cohort study is designed to investigate the association between air pollutants exposure and physiological or pathological reactions on respiratory and cardiovascular system.

Methods/Design

The cohort is a community-based prospective study that includes 4812 individuals aged 18–80 years. The collections of data were conducted from April to May 2011 in Wuhan city and in May 2012 in Zhuhai city. At baseline, data on demographic and socioeconomic information, occupational history, family disease history, lifestyle, cooking mode, daily travel mode, physical activity and living condition have been collected by questionnaires. Participants underwent an extensive physical examination, including anthropometry, spirometry, electrocardiography, and measurements of blood pressure, heart rate, exhaled nitric oxide and carbon monoxide. Potential conditions in the lung, heart, liver, spleen, and skin were synchronously performed. In addition, samples of morning urine, fasting blood serum and plasma were collected during physical health examination. DNA were extracted and were stored at -80°C. Environment concentrations of particulate matter and chemicals were determined for 15 days in each of four seasons. Participants are followed for physiological or pathological changes or incidence of cardiopulmonary diseases every 3 years.

Discussion

The results obtained in WHZH cohort study may increase a better understanding of the relationship between particulate air pollution and its components and possible health damages. And the potential mechanisms underlying the development of cardiopulmonary diseases has implications for the development of prevention and treatment strategies.

【 授权许可】

   
2014 Song et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150218201826833.pdf 526KB PDF download
Figure 2. 49KB Image download
Figure 1. 100KB Image download
【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】
  • [1]Brunekreef B, Holgate S: Air pollution and health. Lancet 2002, 360(9341):1233-1242.
  • [2]SAMET J, Krewski D: Health effects associated with exposure to ambient air pollution. J Toxicol Environ Health A 2007, 70(3–4):227-242.
  • [3]Dockery DW, Pope CA, Xu X, Spengler JD: An association between air pollution and mortality in six US cities. N Engl J Med 1993, 329(24):1753-1759.
  • [4]Samet JM, Dominici F, Curriero FC, Coursac I, Zeger S: Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N Engl J Med 2000, 343(24):1742-1749.
  • [5]Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD: Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287(9):1132-1141.
  • [6]Samoli E, Analitis A, Touloumi G, Schwartz J, Anderson HR, Sunyer J, Bisanti L, Zmirou D, Vonk JM, Pekkanen J, Goodman P, Paldy A, Schindler C, Katsouyanni K: Estimating the exposure–response relationships between particulate matter and mortality within the APHEA multicity project. Environ Health Perspect 2004, 113(1):88-95.
  • [7]Dominici F, McDermott A, Daniels M, Zeger SL, Samet JM: Revised analyses of the national morbidity, mortality, and air pollution study: mortality among residents of 90 cities. J Toxicol Environ Health A 2005, 68(13–14):1071-1092.
  • [8]Pelucchi C, Negri E, Gallus S, Boffetta P, Tramacere I, La Vecchia C: Long-term particulate matter exposure and mortality: a review of European epidemiological studies. BMC Public Health 2009, 9:453. BioMed Central Full Text
  • [9]Kan HD, Chen BH, Chen CH, Wang BY, Fu QY: Establishment of exposure-response functions of air particulate matter and adverse health outcomes in China and worldwide. Biomed Environ Sci 2005, 18(3):159-163.
  • [10]Gao H, Chen J, Wang B, Tan S-C, Lee CM, Yao X, Yan H, Shi J: A study of air pollution of city clusters. Atmos Environ 2011, 45(18):3069-3077.
  • [11]Kan H, Chen B, Hong C: Health impact of outdoor air pollution in China: current knowledge and future research needs. Environ Health Perspect 2009, 117(5):A187.
  • [12]Zhang JF, Mauzerall DL, Zhu T, Liang S, Ezzati M, Remais JV: Environmental health in China: progress towards clean air and safe water. Lancet 2010, 375(9720):1110-1119.
  • [13]Chen B, Hong C, Kan H: Exposures and health outcomes from outdoor air pollutants in China. Toxicology 2004, 198(1–3):291-300.
  • [14]Shang Y, Sun Z, Cao J, Wang X, Zhong L, Bi X, Li H, Liu W, Zhu T, Huang W: Systematic review of Chinese studies of short-term exposure to air pollution and daily mortality. Environ Int 2013, 54:100-111.
  • [15]Zhang H, Cai B: The impact of tobacco on lung health in China. Respirology 2003, 8(1):17-21.
  • [16]Brownson RC, Alavanja MC, Caporaso N, Simoes EJ, Chang JC: Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev 1998, 20(2):218-236.
  • [17]Siedlinski M, Cho MH, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, Silverman EK: Genome-wide association study of smoking behaviours in patients with COPD. Thorax 2011, 66(10):894-902.
  • [18]Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, Himes BE, Levin AM, Mathias RA, Hancock DB, Baurley JW, Eng C, Stern DA, Celedon JC, Rafaels N, Capurso D, Conti DV, Roth LA, Soto-Quiros M, Togias A, Li X, Myers RA, Romieu I, Van Den Berg DJ, Hu D, Hansel NN, Hernandez RD, Israel E, Salam MT, Galanter J, et al.: Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011, 43(9):887-892.
  • [19]Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S, Fujita K, Miyatake A, Enomoto T, Miyagawa T, Adachi M, Tanaka H, Niimi A, Matsumoto H, Ito I, Masuko H, Sakamoto T, Hizawa N, Taniguchi M, Lima JJ, Irvin CG, Peters SP, Himes BE, Litonjua AA, Tantisira KG, Weiss ST, Kamatani N, Nakamura Y, Tamari M: Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011, 43(9):893-896.
  • [20]Wan YI, Shrine NR, Soler Artigas M, Wain LV, Blakey JD, Moffatt MF, Bush A, Chung KF, Cookson WO, Strachan DP, Heaney L, Al-Momani BA, Mansur AH, Manney S, Thomson NC, Chaudhuri R, Brightling CE, Bafadhel M, Singapuri A, Niven R, Simpson A, Holloway JW, Howarth PH, Hui J, Musk AW, James AL, Brown MA, Baltic S, Ferreira MA, Thompson PJ, et al.: Genome-wide association study to identify genetic determinants of severe asthma. Thorax 2012, 67(9):762-768.
  • [21]Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, Huffman JE, Igl W, Albrecht E, Deloukas P, Henderson J, Granell R, McArdle WL, Rudnicka AR, Barroso I, Loos RJ, Wareham NJ, Mustelin L, Rantanen T, Surakka I, Imboden M, Wichmann HE, Grkovic I, Jankovic S, Zgaga L, Hartikainen AL, et al.: Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010, 42(1):36-44.
  • [22]Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, Albrecht E, Jackson CM, Evans DM, Cadby G, Fornage M, Manichaikul A, Lopez LM, Johnson T, Aldrich MC, Aspelund T, Barroso I, Campbell H, Cassano PA, Couper DJ, Eiriksdottir G, Franceschini N, Garcia M, Gieger C, Gislason GK, Grkovic I: Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011, 43(11):1082-1090.
  • [23]Zeller T, Blankenberg S, Diemert P: Genomewide association studies in cardiovascular disease–an update 2011. Clin Chem 2012, 58(1):92-103.
  • [24]Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB: A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5(3):e1000421.
  • [25]Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC: Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61(9):817-827.
  • [26]Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, Barnes PJ: Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax 1998, 53(10):867-870.
  • [27]Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ: Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998, 53(8):668-672.
  • [28]Krzyzanowski M, Cohen A: Update of WHO air quality guidelines. Air Qual Atmosphere Health 2008, 1(1):7-13.
  • [29]Shu XO, Gao YT, Yuan JM, Ziegler RG, Brinton LA: Dietary factors and epithelial ovarian cancer. Br J Cancer 1989, 59(1):92-96.
  • [30]Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, Gao YT, Zheng W: Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women’s Health Study. Eur J Clin Nutr 2004, 58(1):17-23.
  • [31]Wendel-Vos G: Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003, 56(12):1163-1169.
  • [32]Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213.
  • [33]Middleton ET, Morice AH: Breath carbon monoxide as an indication of smoking habit. Chest 2000, 117(3):758-763.
  • [34]Society AT, Society ER: ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171(8):912-930.
  • [35]American Thoracic Society: Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152(3):1107-1136.
  • [36]Li X, Feng Y, Deng H, Zhang W, Kuang D, Deng Q, Dai X, Lin D, Huang S, Xin L, He Y, Huang K, He M, Guo H, Zhang X, Wu T: The dose–response decrease in heart rate variability: any association with the metabolites of polycyclic aromatic hydrocarbons in coke oven workers? PLoS One 2012, 7(9):e44562.
  • [37]Feng Y, Sun H, Song Y, Bao J, Huang X, Ye J, Yuan J, Chen W, Christiani DC, Wu T, Zhang X: A community study of the effect of polycyclic aromatic hydrocarbon metabolites on heart rate variability based on the Framingham risk score. Occup Environ Med 2014, 71(5):338-345.
  • [38]Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gills CR, Hawthorne VM: Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996, 313(21):711-715.
  • [39]Sin DD, Wu L, Man SF: The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005, 127(6):1952-1959.
  • [40]Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC: Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58(5):388-393.
  • [41]Mazzoli-Rocha F, Fernandes S, Einicker-Lamas M, Zin WA: Roles of oxidative stress in signaling and inflammation induced by particulate matter. Cell Biol Toxicol 2010, 26(5):481-498.
  • [42]Lubinski W, Toczyska I, Chcialowski A, Plusa T: Influence of air pollution on pulmonary function in healthy young men from different regions of Poland. Ann Agric Environ Med 2005, 12(1):1-4.
  • [43]Ehrlich RI, Myers JE, te Water Naude JM, Thompson ML, Churchyard GJ: Lung function loss in relation to silica dust exposure in South African gold miners. Occup Environ Med 2011, 68(2):96-101.
  • [44]Shieh TS, Chung JJ, Wang CJ, Tsai PJ, Kuo YC, Guo HR: Pulmonary function, respiratory symptoms, and dust exposures among workers engaged in early manufacturing processes of tea: a cohort study. BMC Public Health 2012, 12:121. BioMed Central Full Text
  • [45]Rojas-Martinez R, Perez-Padilla R, Olaiz-Fernandez G, Mendoza-Alvarado L, Moreno-Macias H, Fortoul T, McDonnell W, Loomis D, Romieu I: Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med 2007, 176(4):377-384.
  • [46]Roy A, Hu W, Wei F, Korn L, Chapman RS, Zhang JJ: Ambient particulate matter and lung function growth in Chinese children. Epidemiology 2012, 23(3):464-472.
  • [47]Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93(5):1043-1065.
  • [48]Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D: Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996, 94(11):2850-2855.
  • [49]Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G: Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003, 42(6):1106-1111.
  • [50]Thayer JF, Yamamoto SS, Brosschot JF: The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 2010, 141(2):122-131.
  • [51]National Bureau of Statistics of China: Communique of the National Bureau of Statistics of People’s Republic of China on Major Figures of the 2010 Population Census (No. 1) 2011. http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/201104/t20110428_30327.html webcite (6 July 2013, date last accessed)
  文献评价指标  
  下载次数:45次 浏览次数:7次